Paper Details

Paper Title

Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer Types.

Paper Journal Title

Clin Cancer Res

Paper Citation Count

Paper Publication Year

2019

Bio Mention

Mesh Descriptor

Author Name	Affiliation
Mohammed Alshalalfa	Helen Diller Family Comprehensive Cancer Center, University of California san francisco
Mohammed Alshalalfa	Dana-Farber Cancer Institute and Brigham and Women's Hospital
Yang Liu
Brandon A Mahal	Dana-Farber Cancer Institute and Brigham and Women's Hospital
David A Quigley	Helen Diller Family Comprehensive Cancer Center, University of California san francisco
Elai Davicioni
Timothy R Rebbeck	Harvard T.H. Chan School of Public Health
Philip W Kantoff	Memorial Sloan Kettering Cancer Center
Philip W Kantoff	Memorial Sloan Kettering Cancer Center
Christopher A Maher	McDonnell Genome Institute, Washington University in St. Louis
Christopher A Maher	Washington University in St. Louis
Christopher A Maher	McDonnell Genome Institute, Washington University in St. Louis
Christopher A Maher	Washington University in St. Louis
Christopher A Maher	Washington University in St. Louis
Christopher A Maher	Washington University in St. Louis
Eric J Small	Helen Diller Family Comprehensive Cancer Center, University of California san francisco
Eric J Small	University of California san francisco
Paul L Nguyen	Dana-Farber Cancer Institute and Brigham and Women's Hospital
Felix Y Feng	Helen Diller Family Comprehensive Cancer Center, University of California san francisco
Felix Y Feng	University of California san francisco

Column Actions